StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.70−0.05 (-6.46%)

Close on Oct 19, 2026Market cap $1.45MP/E –Yield –

Bluejay Diagnostics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Bluejay Diagnostics's gross profit for the twelve months ending Dec 31, 2022 was $48.91K. For fiscal 2022 it was $48.91K.

Annual gross profit

PeriodPeriod endValueChange
FY2022Dec 31, 2022$48.91K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$48.91K–

More Bluejay Diagnostics figures

See a number that looks wrong?